Results and discussion
To identify residues of Raf1 involved in its integrin-induced activation and to establish whether any of these sites are regulated by PI 3-kinase, we first examined the ability of fibronectin to activate variants of Raf1 containing alterations in known phosphorylation sites (Figure 1a ). Wild-type and mutant variants of Raf were transiently expressed in COS7 cells and Raf1 activity was examined in immunoprecipitates from cells held in suspension or attached to fibronectin for 15 minutes. The dependence of this activation on PI 3-kinase was determined by its sensitivity to wortmannin, a pharmacological inhibitor of PI 3-kinase.
As previously reported, wild-type Raf1 was activated by attachment of cells to fibronectin and this activation was inhibited by 50 nM wortmannin (Figure 1b,c) [1] . Mutation of Ser621 to alanine (Figure 1b) prevented activation of Raf following attachment to fibronectin. Mutation of the tandem serines at positions 338 and 339 also blocked fibronectin-induced activation (Figure 1b) . The residual activity detected after fibronectin stimulation was insensitive to wortmannin. Mutation of Ser339 alone (S339A) had no detectable effect on activation by fibronectin nor its sensitivity to wortmannin inhibition (Figure 1c) . Mutation of Ser338 to alanine (S338A), however, prevented activation by fibronectin (Figure 1c ). These results indicate that Ser338 is required for activation of Raf1 by fibronectin receptors. Others have shown that loss of the Ser338 phosphorylation site also blocks Raf1 activation by activated oncogenic V12Ras, υ-Src, EGF, PDGF and phorbol esters [2, 3] .
The S259A, T268A/T269A, S497A and S499A mutants of Raf1 retained their ability to be activated by fibronectin and, in each case, this activation was sensitive to wortmannin (see Supplementary material). Thus, the Thr268 autophosphorylation site, the Ser259 site of 14-3-3 binding and Akt phosphorylation [4] , Ser497 and Ser499, putative sites of phosphorylation by PKC and ceramide-activated kinase (reviewed in [5] ), are not required for integrin activation of Raf1. The Y340A/Y341A double mutant also showed no defect in its activation by fibronectin (see Supplementary material). A second Raf1 variant in which these two tyrosine residues were replaced by phenylalanines (Y340F/Y341F) showed a weaker activation upon fibronectin attachment, yet this activation was inhibited by wortmannin (see Supplementary material). These results suggest that phosphorylation of Tyr340 and Tyr341 does not play a significant role in integrin stimulation of Raf1. We were unable to detect an inducible tyrosine phosphorylation of Raf1 after fibronectin-dependent adhesion of COS7 cells (data not shown). Although this could reflect unstable phosphorylation at these sites, the evidence that both the Y340A/Y341A and Y340F/Y341F mutants retained the ability to be inducibly activated upon adhesion to fibronectin and that this activation was sensitive to wortmannin treatment suggests that these sites do not play a significant role in PI 3-kinase-regulation of integrin-mediated Raf1 activation.
In summary, mutation of two phosphorylation sites, Ser621 and Ser338, prevented activation of Raf1 upon attachment of cells to fibronectin. We chose to focus on Ser338 as a critical site in integrin stimulation and as a potential target of PI 3-kinase regulation because the Raf1 S621A mutant shows no activity in the basal state and Ser621 is phosphorylated constitutively [6] . To investigate whether Raf1 Ser338 is phosphorylated after integrin stimulation and whether this phosphorylation is dependent on PI 3-kinase, we used a phospho-specific antiserum that recognizes phosphorylated Ser338 [2] . Upon adhesion of cells to fibronectin, Raf1 was inducibly phosphorylated on Ser338 and this phosphorylation was inhibited by 50 nM wortmannin (Figure 2a ). These data indicate that fibronectin receptors stimulate a PI 3-kinasedependent phosphorylation of Raf1 Ser338 in COS7 cells.
A dominant-inhibitory Pak-1 mutant blocks phosphorylation of Raf1 Ser338
Protein kinases of the Pak family have recently been implicated in the regulation of Raf through Ser338 phosphorylation. Pak-3 phosphorylates Raf1 Ser338 in vitro [2, 3] and overexpression of constitutively active Pak-3 leads to phosphorylation of Ser338 in vivo. In addition, overexpresssion of a kinase-inactive Pak-3 mutant significantly reduces the basal activity of the membrane-targeted Raf-CX and the V12Ras-inducible activation of wild-type Raf1 [2] . These data and the evidence that Pak-1 is activated by integrin receptor engagement [7] led us to investigate whether fibronectin-induced Ser338 phosphorylation is affected by a dominant-inhibitory Pak-1 mutant. We coexpressed a kinase-inactive Pak-1 mutant (Pak-1 K298A) with Raf1 in COS7 cells and examined Ser338 phosphorylation (Figure 2a ). The phosphorylation of Ser338 was indeed inhibited upon coexpression of this Pak-1 variant. Coexpression of V12Ras with Raf1 was used as a positive control (Figure 2a ) because this is known to induce a high level of Ser338 phosphorylation [2] . These data suggest that Pak family kinases are involved in fibronectin stimulation of Ser338 phosphorylation.
Activation of the Raf1 S338D/S339E mutant is independent of PI 3-kinase
To further investigate the role of Ser338 in PI 3-kinase regulation of Raf, we examined the response of the Raf1 S338D/S339E double mutant to PI 3-kinase inhibition. This mutant is a chemical mimic of Raf1 doubly phosphorylated on serine residues 338 and 339. Although this mutant showed a 4-5-fold lower basal activity than wildtype Raf1, this activity was still stimulated significantly (2-3-fold) following attachment of cells to fibronectin. It is noteworthy that we consistently observed no inhibition of this fibronectin-induced activity by wortmannin (Figure 2b and see Supplementary material), nor upon coexpression with a dominant-negative mutant of the p85 subunit of PI 3-kinase (∆p85 PI 3-kinase; Figure 2c ), suggesting that mimicking the phosphorylation of Raf1 Ser338 and Ser339 circumvents the dependence on PI 3-kinase. As observed previously [8] , the S338D/S339E mutant did not show elevated basal activity, most likely because Ras interaction is required to relieve negative regulatory interactions involving the amino-terminal half of Raf1. The lower stimulated kinase activity of this mutant compared with wild type might reflect the inability of the S338D/S339E substitution to exactly mimic phosphorylation of Ser338 and Ser339.
Integrin-induced activation of Pak-1 is dependent on PI 3-kinase
Because our results ( Figure 2a ) and a previous report [2] have implicated Pak in Ser338 phosphorylation and the phosphorylation of this site was blocked by inhibition of PI 3-kinase activity, we examined whether integrin activation of Pak-1 was sensitive to PI 3-kinase inhibition. Fibronectin was previously shown to induce a strong activation of Pak-1 in NIH3T3 fibroblasts [7] ; however, the PI 3-kinase-dependence of this activation was not examined. Upon attachment of COS7 cells to fibronectin, Pak-1 was activated 12-fold compared with cells held in suspension (Figure 3a and see Supplementary material). Approximately 80% of this activation was sensitive to inhibition by 50 nM wortmannin. This result suggests that PI 3-kinase is required for Pak stimulation by fibronectin receptors.
Expression of kinase-inactive Pak-1 reduces Raf activation
To further explore the role of Pak in Raf regulation, we examined the effects of Pak-1 on the kinase activity of Raf1. We have shown that kinase-inactive Pak-1 inhibits Raf1 Ser338 phosphorylation following fibronectin stimulation; however, it was of interest to directly examine the effect of this Pak-1 mutant on fibronectin stimulation of Raf1 kinase activity. Pak-1 K298A was coexpressed with Raf1 in COS7 cells and Raf1 kinase activity was measured in vitro. Coexpression of Pak-1 K298A caused a 50% inhibition in the activation of Raf1 by fibronectin (Figure 3b and see Supplementary material). The residual Raf1 activation was consistently insensitive to inhibition by 50 nM wortmannin. This wortmannin-insensitivity and the evidence that kinase-inactive Pak-1 was less effective in blocking Raf1 activation than wortmannin raise the possibility that kinase-inactive Pak-1 might stimulate alternative mechanisms, independent of PI 3-kinase and Raf1 Ser338, that lead to Raf1 activation. Kinase-inactive mutants of Pak-1 induce very dramatic cytoskeletal alterations [9] , indicating that regions outside the catalytic domain (for example, the proline-rich regions which bind to PIX and Nck) can activate intracellular signaling pathways.
This report provides new insights into one mechanism by which PI 3-kinase can regulate activation of the Erk pathway through Raf1. These studies raise the question of how integrins can regulate Pak through a PI 3-kinasedependent mechanism and suggest the model shown in the Supplementary material. Tracing this proposed pathway backwards from Pak, the Pak family kinases are known to be regulated by binding Cdc42 or Rac [9] . Because PI 3-kinase regulates guanine nucleotide Brief Communication 553 Figure 2 (a) Inducibility of Raf1 Ser338 phosphorylation upon attachment to fibronectin and its inhibition by wortmannin and by coexpression of kinase-inactive Pak-1. COS7 cells expressing FLAG-tagged Raf1 alone, or FLAG-tagged Raf1 in combination with Myc-tagged Pak-1 K298A or V12Ras were serum-starved and left attached (Ad), detached and held in suspension (S), or detached and plated on fibronectin-coated dishes (F). Cells used in lanes 4 and 8 were treated with 50 nM wortmannin (+). Phosphorylation of Ser338 was detected using an antiserum specific for phospho-Ser338. The lower panel shows the same immunoblot reprobed with anti-Raf antiserum after stripping the PVDF membrane. This figure is representative of data obtained in two separate experiments. (b,c) Activation of Raf1 S338D/S339E on fibronectin is insensitive to inhibition by wortmannin and ∆p85 PI 3-kinase. In vitro kinase assays were performed using Raf1 immunoprecipitated from cells expressing either WT Raf1 or S338D/S339E Raf1 alone or either of these together with ∆p85 PI 3-kinase, as indicated. Upper panels show Raf1 kinase assays using GST-KD-MEK1 as substrate. Lower panels show the corresponding Raf1 protein immunoblot. Cells were treated as described in (a).
exchange factors (GEFs) for Cdc42 and Rac (for example, Vav [10] , SOS [11] , PIX/Cool [12] ) and is required for Racmediated events [13] , PI 3-kinase regulation of Pak could be mediated through the activation of Rac or Cdc42 GEFs. Pix/Cool is one such possible exchange factor because it binds directly to Pak and is regulated by PI 3-kinase [12, 14] . PI 3-kinase activation by integrins and growth factors depends on interaction of the p110 catalytic subunit of PI 3-kinase with Ras [15] . Therefore, fibronectin-induced Ras-GTP could activate PI 3-kinase, which could then activate a Cdc42 or Rac exchange factor, leading to GTP loading onto Cdc42 or Rac, and thus activation of Pak. The ability of dominant-inhibitory Cdc42 to inhibit Erk activation in Rat1 cells attached to fibronectin [16] is consistent with this possibility. A recent study demonstrating regulation of Raf1 catalytic activity by oncogenic Ras through the stimulation of a pathway involving PI 3-kinase, Cdc42 or Rac, and Pak further supports this proposal [17] .
Supplementary material
Additional methodological details, data on fibronectin-induced activation of Raf1 mutants, quantitation of Raf1 activation data and a model for PI 3-kinase regulation of Raf1 are available at http://currentbiology.com/supmat/supmatin.htm. (a) Activation of Pak-1 on attachment to fibronectin and sensitivity to wortmannin inhibition. An in-gel assay for Pak kinase activity was performed as described previously [7] . Briefly, COS7 cells transfected with Myc-Pak-1 were serum-starved and then left attached to the plate (Ad), held in suspension (S) or plated on fibronectin-coated dishes for 15 min (F) in the presence or absence of wortmannin. Proteins were immunoprecipitated (IP), separated by 12.5% SDS-PAGE, and kinase activities assayed in situ. 
